EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study

Shaoxing Chen iD, Xiaohuang Yang, Shaona Jiang, Yina Lin, Leijuan Huang, Huiqin Chen, Jinzhu Zheng, Yuanfu Xie, Zhixing Kuang iD

PLOS One · 10.06.2026 · 21 (6) · e0351539

DOI: 10.1371/journal.pone.0351539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 10.06.2026. Verfasst von Shaoxing Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China. Hauptthemen laut MEDLINE: Global Burden of Disease, Breast Neoplasms, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Female-specific cancers represent a substantial public health challenge in China. This study was designed to evaluate temporal trends and generate future projections of the burden associated with female-specific cancers in China from 1990 to 2023.

Methods

Data on incidence, mortality, and disability-adjusted life-years (DALYs) attributable to breast, cervical, uterine, and ovarian cancers among women in China were extracted from the Global Burden of Disease (GBD) 2023 database. Joinpoint analysis was used to assess temporal trends, whereas decomposition analysis was applied to quantify the contributions of epidemiological changes, population growth, and ageing to changes in disease burden; a Bayesian age-period-cohort (BAPC) model was further used to project trends in disease burden over the next 15 years.

Results

Between 1990 and 2023, all age-standardized rates (ASRs) of female-specific cancers in China declined except for the age-standardized incidence rate (ASIR) of breast cancer, which increased from 24.54 (95% uncertainty interval [UI]: 19.7–30.79) per 100,000 in 1990 to 31.62 (95% UI: 25.4–38.22) per 100,000 in 2023. The absolute disease burden increased, with 342,725 (95% UI: 270,872–413,171) new breast cancer cases in 2023, representing a 187.24% increase. In contrast, the numbers of new cases of cervical, uterine, and ovarian cancers were 124,686 (95% UI: 77,638–165,722), 74,990 (95% UI: 53,630–119,885), and 38,969 (95% UI: 31,914–46,805), respectively, with corresponding increases of 43.63%, 82.97%, and 61.76%. Population aging and growth were the main contributing factors, and the BAPC model projected that the absolute disease burden of all four female-specific cancers would continue to increase in the future.

Conclusion

The burden of female-specific cancers in China remains substantial, underscoring the urgent need to develop targeted prevention and intervention strategies to mitigate this burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Global Burden of DiseaseBreast NeoplasmsUterine Cervical NeoplasmsFemaleChinaHumansIncidenceMiddle AgedDisability-Adjusted Life YearsAdultAgedBayes TheoremOvarian Neoplasms

Autor:innen und Institutionen

  • Department of Radiation Oncology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China.
  • Department of Gastroenterology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China.
  • Department of Health Management Center, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China.
  • Department of Radiotherapy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.

ORCID-Profile: Shaoxing Chen, Zhixing Kuang

Zitieren

APA

Chen, S., Yang, X., Jiang, S., Lin, Y., Huang, L., Chen, H., Zheng, J., Xie, Y., & Kuang, Z. (2026). Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study. PLOS One, 21(6), e0351539. https://doi.org/10.1371/journal.pone.0351539

Vancouver

Chen S, Yang X, Jiang S, Lin Y, Huang L, Chen H, et al. Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study. PLOS One. 2026;21(6):e0351539. doi:10.1371/journal.pone.0351539

BibTeX
@article{Chen2026,
  author = {Chen, Shaoxing and Yang, Xiaohuang and Jiang, Shaona and Lin, Yina and Huang, Leijuan and Chen, Huiqin and Zheng, Jinzhu and Xie, Yuanfu and Kuang, Zhixing},
  title = {Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0351539},
  doi = {10.1371/journal.pone.0351539}
}
Kostenlos starten →